LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)

Evaluation of the Depigmenting Effect of Liftactiv B3 Serum (Split Face) in Patients With Mild to Moderate Facial Post-acne PIHP for 3 Months

The purpose of this research study is to measure the depigmenting effect of a serum product called Liftactiv B3 in patients with mild to moderate facial PIHP (Post Inflammatory Hyper Pigmentation)

Inclusion Criteria:

• Multiethnic subjects
• 18 to 50 YO
• Phototype III-VI
• All skin types
• 50% with sensitive skin (declarative)
• Symmetrical mild to moderate facial post-acne PIHP lesions with IGA scale
• Mild active acne (less than 10 retention and 5 inflammatory lesions)
• Agreeing not to change their lifestyle during the study period.
• Capable of reading the documents presented to them, of adhering to the study regulations and accepting the limitations.
• Available to follow the study
• Agreeing to participate and having signed the informed consent

Exclusion Criteria:

• Moderate to severe active acne
• Patients under topical or systemic retinoids
• Patients under systemic immunosuppressants
• Patients under active treatment of PIHP (including topicals or procedures) within the last 3 months
• Patients treated with facial procedures within the last 3 months
• Pregnancy
• Patient with a recent change in contraception (since less than 6 months)
• Known allergy to any component of tested product
• Not presenting with the conditions needed to comply with the protocol.
• Unable to give their informed consent
• Not available to follow the study in its entirety